Chopra says Linde/Praxair remedy not enough
The Federal Trade Commission should not have allowed the Linde/Praxair merger to go forward, a Democratic commissioner has said, criticising the proposed remedies and calling for the FTC to look harder at private equity buyers of divested assets.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10